EN
HI
Marksans Pharma Chart
Marksans Pharma Share Key Metrics
Volume
5.75 L
Market Cap
8139.25 CR
LTQ@LTP
1@179.56
ATP
178.43
Var Margin
20.6 %
Circuit Range
141.42-212.12
Delivery %
51.09 %
Value
10.25 CR
ASM/GSM
No
Market Lot
1
Summary
Marksans Pharma share price stands at ₹179.56 at 22 Apr, 2026 | 15:59. The stock Marksans Pharma intraday movement has stayed between ₹175.85 and ₹180.11, while on a 52-week basis it has fluctuated from ₹155.00 to ₹270.70.
In terms of trading activity, Marksans Pharma has recorded a volume of 574533 shares. The Marksans Pharma has a market cap of ₹453288438. The stock’s Average Traded Price (ATP) stands at ₹17843, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1, 17956.
The Marksans Pharma operates within a circuit range of ₹141.42-212.12 – ₹141.42-212.12, with a Value of ₹10.25 CR. The Delivery Percentage for the day is 51.09%. Additionally, Marksans Pharma currently falls under the No framework, and trades with a market lot size of 1.
Marksans Pharma Fundamentals
View MoreP/E Ratio
22.25
P/B Ratio
2.86
Div. Yield
0.45
Sector P/E
63.84
Sector P/B
3.48
Sec. Div. Yield
0.57
Marksans Pharma Resistance and Support
Pivot 177.07
Resistance
First Resistance
178.61
Second Resistance
180.44
Third Resistance
181.98
Support
First Support
175.24
Second Support
173.7
Third Support
171.87
Marksans Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-05 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-19 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
Marksans Pharma News
Marksans Pharma Limited
Marksans Pharma received USFDA final approval for Benzonatate Capsules USP, 100 mg & 200 mg (Rx). This approval signifies a market entry for a product bioequivalent to Pfizer's Tessalon Capsules, addressing respiratory conditions like cough and bronchitis.
Apr 01 2026 12:04:00
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Marksans Pharma received USFDA final approval for Benzonatate Capsules USP, 100 mg & 200 mg (Rx). This product is bioequivalent and therapeutically equivalent to Pfizer Inc.'s Tessalon Capsules, expanding the company's respiratory segment.
Apr 01 2026 12:04:00
About Marksans Pharma
NSE : 10579
BSE : 524404
ISIN : INE750C01026
Marksans Pharma Management
| Name | Position |
|---|---|
| Harshavardhan Panigrahi | Company Secretary & Compliance Officer |
| Mark Saldanha | Chairman & Managing Director |
Marksans Pharma Similar Stocks
Healthcare Global Enterprises Ltd.
578.30
3.60 (0.63%)
Jupiter Life Line Hospitals Ltd.
1292.20
1.30 (0.10%)
Akums Drugs & Pharmaceuticals Ltd.
528.75
-5.55 (1.04%)
Sanofi India Ltd.
3500.00
-84.00 (2.34%)
Shilpa Medicare Ltd.
408.35
3.10 (0.76%)
Sudeep Pharma Ltd.
675.00
16.80 (2.55%)
Yatharth Hospital & Trauma Care Services Ltd.
740.85
-4.75 (0.64%)
Blue Jet Healthcare Ltd.
416.85
1.55 (0.37%)
Thyrocare Technologies Ltd.
395.60
8.10 (2.09%)
Aarti Pharmalabs Ltd.
693.95
-12.75 (1.80%)
Marksans Pharma FAQs
The Buying Price of Marksans Pharma share is 179.56 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Marksans Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Marksans Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Marksans Pharma shares is 22.25. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Marksans Pharma shares is 2.86. Useful to assess the stock's value relative to its book value.
To assess Marksans Pharma’s valuation compare Sector P/E, P/B which are 63.84 & 3.48 with sector averages, along with growth rates and financial metrics.
The Market Cap of Marksans Pharma is 8139.25 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Marksans Pharma share price is 270.70 & 155.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Marksans Pharma belongs to the Healthcare sector.
